These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16705058)

  • 21. Triheptanoin for the treatment of brain energy deficit: A 14-year experience.
    Mochel F
    J Neurosci Res; 2017 Nov; 95(11):2236-2243. PubMed ID: 28688166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triheptanoin partially restores levels of tricarboxylic acid cycle intermediates in the mouse pilocarpine model of epilepsy.
    Hadera MG; Smeland OB; McDonald TS; Tan KN; Sonnewald U; Borges K
    J Neurochem; 2014 Apr; 129(1):107-19. PubMed ID: 24236946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders.
    Sklirou E; Alodaib AN; Dobrowolski SF; Mohsen AA; Vockley J
    Front Genet; 2020; 11():598760. PubMed ID: 33584796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triheptanoin Alleviates Ventricular Hypertrophy and Improves Myocardial Glucose Oxidation in Rats With Pressure Overload.
    Nguyen TD; Shingu Y; Amorim PA; Schwarzer M; Doenst T
    J Card Fail; 2015 Nov; 21(11):906-15. PubMed ID: 26209001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triheptanoin for the treatment of long-chain fatty acid oxidation disorders: Final results of an open-label, long-term extension study.
    Vockley J; Burton BK; Berry G; Longo N; Phillips J; Sanchez-Valle A; Chapman KA; Tanpaiboon P; Grunewald S; Murphy E; Lu X; Rahman S; Ray K; Reineking B; Pisani L; Ramirez AN
    J Inherit Metab Dis; 2023 Sep; 46(5):943-955. PubMed ID: 37276053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary management and major clinical events in patients with long-chain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin study.
    Vockley J; Longo N; Madden M; Dwyer L; Mu Y; Chen CY; Cataldo J
    Clin Nutr ESPEN; 2021 Feb; 41():293-298. PubMed ID: 33487279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders.
    Zöggeler T; Stock K; Jörg-Streller M; Spenger J; Konstantopoulou V; Hufgard-Leitner M; Scholl-Bürgi S; Karall D
    Orphanet J Rare Dis; 2021 Jan; 16(1):28. PubMed ID: 33446227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin treatment of rats with diet-induced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver.
    Tessari P; Tiengo A
    Acta Diabetol; 2008 Sep; 45(3):143-5. PubMed ID: 18357405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models.
    Willis S; Stoll J; Sweetman L; Borges K
    Neurobiol Dis; 2010 Dec; 40(3):565-72. PubMed ID: 20691264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24weeks of treatment.
    Vockley J; Burton B; Berry GT; Longo N; Phillips J; Sanchez-Valle A; Tanpaiboon P; Grunewald S; Murphy E; Humphrey R; Mayhew J; Bowden A; Zhang L; Cataldo J; Marsden DL; Kakkis E
    Mol Genet Metab; 2017 Apr; 120(4):370-377. PubMed ID: 28189603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid changes in liver lipid composition and pancreatic islet K+ handling and secretory behaviour provoked by the intravenous administration of a medium-chain triglyceride: fish oil emulsion to long-chain polyunsaturated omega3 fatty acid-depleted rats.
    Louchami K; Zhang Y; Oguzhan B; Delporte C; Portois L; Carpentier YA; Genten F; Danguy A; Malaisse WJ; Sener A
    Int J Mol Med; 2006 Dec; 18(6):1047-55. PubMed ID: 17089007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of triheptanoin (UX007) in patients with long-chain fatty acid oxidation disorders: Results from an open-label, long-term extension study.
    Vockley J; Burton B; Berry G; Longo N; Phillips J; Sanchez-Valle A; Chapman K; Tanpaiboon P; Grunewald S; Murphy E; Lu X; Cataldo J
    J Inherit Metab Dis; 2021 Jan; 44(1):253-263. PubMed ID: 32885845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential.
    Roe CR; Mochel F
    J Inherit Metab Dis; 2006; 29(2-3):332-40. PubMed ID: 16763896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fine vs. coarse complete all-in-one admixture infusions over 96 hours in rats: fat globule size and hepatic function.
    Driscoll DF; Ling PR; Silvestri AP; Bistrian BR
    Clin Nutr; 2008 Dec; 27(6):889-94. PubMed ID: 18849096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissociation of mercaptoacetate's effects on feeding and fat metabolism by dietary medium- and long-chain triacylglycerols in rats.
    Mansouri A; Koss MD; Brandt K; Geary N; Langhans W; Leonhardt M
    Nutrition; 2008 Apr; 24(4):360-5. PubMed ID: 18234475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term effects of parenteral nutrition of cholestatic infants with lipid emulsions based on medium-chain and long-chain triacylglycerols.
    Socha P; Koletzko B; Demmelmair H; Jankowska I; Stajniak A; Bednarska-Makaruk M; Socha J
    Nutrition; 2007 Feb; 23(2):121-6. PubMed ID: 17234505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.
    Baumgardner JN; Shankar K; Hennings L; Badger TM; Ronis MJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G27-38. PubMed ID: 17947452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of short-term and long-term treatment with medium- and long-chain triglycerides ketogenic diet on cortical spreading depression in young rats.
    de Almeida Rabello Oliveira M; da Rocha Ataíde T; de Oliveira SL; de Melo Lucena AL; de Lira CE; Soares AA; de Almeida CB; Ximenes-da-Silva A
    Neurosci Lett; 2008 Mar; 434(1):66-70. PubMed ID: 18281154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic potential of triheptanoin in metabolic and neurodegenerative diseases.
    Wehbe Z; Tucci S
    J Inherit Metab Dis; 2020 May; 43(3):385-391. PubMed ID: 31778232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.